Version 1.112 release notes
Release notes
Changes to the NVC have been made since the last release v1.111 (2026-05-07). For your reference, please find a summary of the changes below:
Vaccine lots
- Refer to the 'Vaccine Lots' tab in the Excel workbook to view which specific vaccine lots are new. Column C contains a flag indicating whether a lot is new (marked as 'YES' or 'NO'). You can also find these flags in column O of the 'LotTradenameMapping' tab
Tradenames
- 7131000087109 | [Men-C-ACYW] Menactra | (Updated Fr Display Name and Abbreviation)
- 19351000087108 | [Men-C-ACYW] NIMENRIX (GSK) | (Updated Fr Display Name and Abbreviation)
- 21781000087106 | [Men-C-ACYW] NIMENRIX (Pfiz) | (Updated Fr Display Name and Abbreviation)
- 21681000087101 | [Men-C-ACYW] Menveo (GSK) | (Updated Fr Display Name and Abbreviation)
- 7141000087103 | [Men-C-ACYW] Menveo (NVD) | (Updated Fr Display Name and Abbreviation)
- 7111000087104| [[Men-P-ACYW] MENOMUNE (SP) | (Updated Fr Display Name and Abbreviation)
- 581531000087107 | [Men-C-ACYW] MENVEO solution for injection | Updated generic and market authorization holder mappings)
Vaccine- Preventable Disease
23511006 | Meningococcal disease| (Updated antigen mapping)
Summary of changes
- Tradename immunizing agent: 7
- Vaccine lot: 18
- Version:
- 1.7.0